Kemira, FI0009004824

Kemira stock builds on earnings strength

Published on 07/24/2026 at 13:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Kemira stock is supported by its latest reported margins, cash flow, and dividend framework as investors wait for the next fresh catalyst.

Makroaufnahme weißer Chemiegranulate mit glänzenden Wassertropfen in Nahaufnahme
Kemira Oyj FI0009004824 produziert Koagulations- und Flockungsmittel als Chemikalien für industrielle Wasseraufbereitung weltweit, Illustration mit AI erstellt.

Kemira (FI0009004824) is trading against a backdrop of recent reported earnings strength, with fiscal 2025 net sales at EUR 2,693.4 million, comparable EBIT at EUR 324.1 million, and comparable EBIT margin at 12.0%. The company also reported net cash from operating activities of EUR 280.6 million in fiscal 2025, giving investors a current financial base to assess alongside the share price context.

Margin stays above 12.0%

Kemira's fiscal 2025 comparable EBIT margin of 12.0% was paired with comparable EBIT of EUR 324.1 million on net sales of EUR 2,693.4 million, according to the latest annual-report figures. That margin level is important because it links pricing power and cost discipline to a year in which operating cash generation remained positive at EUR 280.6 million.

The annual report also shows how the company converts earnings into balance-sheet flexibility. For investors, that matters more than a one-line sales headline because it frames how much room Kemira has for dividends, investment, and working capital through 2026.

EUR 2.69 billion revenue

In fiscal 2025, Kemira's EUR 2,693.4 million of net sales give a clear size reference for the business. Compared with the same year, the reported EUR 324.1 million of comparable EBIT and EUR 280.6 million of operating cash flow show that profitability and cash generation stayed aligned instead of diverging.

The most useful comparison is internal rather than market-wide: a 12.0% comparable EBIT margin on EUR 2.69 billion of sales signals that the earnings base remained intact even without needing a dramatic top-line story. That is the kind of number investors track when the share price is judged against the latest report rather than a single headline.

Read deeper

Kemira annual report detail

The latest report is the cleanest source for the 2025 sales, earnings, cash flow, and margin figures that frame the stock today.

Dividend frame matters

Kemira's 2025 earnings profile also matters because the company reported net cash from operating activities of EUR 280.6 million, which supports the dividend discussion and future capital allocation. That cash generation came after a year that left the group with a comparable EBIT margin of 12.0%, a combination that generally reads better than earnings alone.

The share story therefore rests on three dated figures at once: EUR 2,693.4 million in sales, EUR 324.1 million in comparable EBIT, and EUR 280.6 million in operating cash flow, all from fiscal 2025. Those numbers give the stock a measurable base even before the next market-moving update arrives.

Water chemistry core

Kemira's product mix is still anchored in water-intensive industries, where chemistry for municipal and industrial water treatment remains the central revenue engine. That business structure helps explain why comparable EBIT and cash flow matter as much as sales growth when investors look at the latest year.

For a product read-through, the current relevance comes from the company level rather than one launch item: the 2025 figures show how the core portfolio translated into EUR 2,693.4 million of net sales and EUR 324.1 million of comparable EBIT. The business line only becomes more interesting when it can hold that margin above 12.0% through another reporting cycle.

Stock view remains dated

At 24 July 2026, the latest evidential market reference in this file is the fiscal 2025 report rather than a fresh quoted price. That makes the report metrics the main stock anchor for Kemira until a dated market quote is available in the same evidence set.

Kemira stock therefore trades on a simple set of published numbers: EUR 2,693.4 million in 2025 net sales, EUR 324.1 million in comparable EBIT, and EUR 280.6 million in operating cash flow. The next market reaction will depend on whether those figures are maintained or improved in the following reporting period.

Kemira stock fact box

  • Company: Kemira Oyj
  • ISIN: FI0009004824
  • Ticker: HEL: KEMIRA
  • Trading venue: Nasdaq Helsinki
  • Sector / Industry: Materials / Specialty Chemicals
  • Index membership: OMX Helsinki 25

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | FI0009004824 | KEMIRA | boerse | 69862122 | bgmi